This order is subject to initial advance payment as per the agreed terms of the contract and this order will be executed within 6 to 8 months.
This order is subject to initial advance payment as per the agreed terms of the contract
Yinjia Biosciences will provide Porton Advanced with high-quality core protein raw materials and testing reagent products for quality control and evaluation systems.
The safety profile of LAGEVRIO in this trial was generally consistent with that observed in previously reported clinical studies
The new company will utilize Teijin's drug discovery research technologies, facilities, equipment and personnel.
The new sterile filling line meets cGMP aseptic filling regulatory requirements
Fluor is providing architectural and engineering services and procuring equipment for the new 275,000 square-foot manufacturing facility that will house two manufacturing lines to double manufacturing capability
With the new facility, the company underlines its commitment to meet the substantially growing demand for its MCC
The investment enhances Lonza’s capabilities and flexibility to support both clinical and commercial supply and will play a key role in meeting the growing market demand for bioconjugates
The company's consolidated revenues for the quarter grew 36% to Rs. 3,020 crore on the back of robust performance across all its three businesses
Subscribe To Our Newsletter & Stay Updated
